Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results
Date:3/8/2010

GAAP net income -continuing operations 12,511 (49,239) * 53,432 (14,951) * GAAP net margin -continuing operations 17% (76%) 20% (6%) Adjustments: Share-based compensation 2,972 3,521 10,220 13,046 Amortization of acquired intangible assets 764 3,896 3,057 11,175 Impairment charge 60,497 60,497 Deferred tax impact related to acquired intangible assets (296) (8,648) (1,184) (11,502) Non-GAAP net income 15,951 10,027 59% 65,525 58,265 12% Non-GAAP net margin 22% 16% 24% 23% GAAP net income 12,127 (93,851) * 52,874 (64,203) * Add back: Depreciation and amorti- zation 6,726 6,264 23,974 30,587 Interest (income) expenses, net (102) (270) (57) (913) Income tax expenses (benefit) 478 (15,283) 5,143 (16,429) EBITDA 19,229 (103,140) * 81,934 (50,958) * Adjustments: Share-based compensation 2,972 3,521 10,220 13,046 Mark-to-market 1,226 626 (481) 2,758 losses (gains) on foreign- exchange forward contracts Impairment charge -continuing operations 60,497 60,497 Impairment charge-dis- continued operations 591 49,581 591 49,581 Adjusted EBITDA 24,018 11,085 * 92,264 74,924 23% Income attri- butable to holders of ADS (
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. WuXi PharmaTech (NYSE: WX) Holds Its Third Life Science and Chemistry Awards Ceremony in Beijing
2. WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening
3. WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
4. Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline
5. WuXi PharmaTech Announces Second-Quarter 2009 Results
6. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting
7. WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
8. WuXi PharmaTech Receives Award from BASF
9. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
10. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
11. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... Further Development Of AeroLEF As President Of ... ... BioSciences Inc.,(AMEX: YMI , TSX: YM, AIM: YMBA), an oncology ... that the Clinical Hold imposed by the US Food and Drug,Administration ...
... Antibody Targets in the Areas of Cancer, Stem Cell and ... ... 19 Sigma-Aldrich (Nasdaq:,SIAL) today announced it has entered into ... of monoclonal antibodies.,Scientists at the University of California, San Francisco ...
... on Friday, June 20, 2008, NEW YORK, June ... plaintiffs, litigation law firms in America, filed a lawsuit ... York City Fire,Department Emergency Medical Technician whose diabetes was ... Armstead, was one,of the many brave responders on the ...
Cached Biology Technology:YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL 2YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL 3Sigma-Aldrich Announces Collaboration to Develop Monoclonal Antibodies 2Sigma-Aldrich Announces Collaboration to Develop Monoclonal Antibodies 3Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca 2
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition ... individuals. Facial recognition system measures the overall facial ... edges, mouth, and the distance between eyes. Facial ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced ... India 2015-2019" report to their offering. ... market is the adoption of multimodal biometric systems. ... of an individual for verification and identification purposes. ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... of Pharmaceutical Scientists (AAPS) is a professional, scientific ... academia, government and other research institutes worldwide. Founded ... for the exchange of knowledge among scientists to ... timely scientific programs, on-going education, information resources, and ...
... / b3c newswire / - NiKem Research is ... Ministry of Health, GLP certification of its bioanalysis facilities to ... has provided for many years high quality cost-effective bioanalytical support ... in vivo PK services associated to various drug ...
... September 14, 2009 / b3c newswire / - ... events for the healthcare, education and energy markets, and ... to the scientific community, today announced the initial slate ... BioConference Live is the first of its kind online-only ...
Cached Biology News:AAPS and PhRMA co-sponsor stability workshop 2NiKem Research receives certification for GLP Bioanalysis 2BioConference Live Attracts Major Life Science Sponsors 2BioConference Live Attracts Major Life Science Sponsors 3
Rabbit polyclonal to Peptide E ( Abpromise for all tested applications)....
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
...
...
Biology Products: